Cargando…
Precision Medicine & Pharmacogenomics: Personalized Medication in Neuropsychiatric Disorders using AI and telepsychiatry
INTRODUCTION: The term “personalised therapy” refers to the use of genetic data to better treat or determine the predisposition to a specific genetic disease, with the ultimate goal of improving quality of life. Telepsychiatry and AI are key to support it.. OBJECTIVES: Determine benefits of pharmaco...
Autor principal: | Gkouvas, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567712/ http://dx.doi.org/10.1192/j.eurpsy.2022.1745 |
Ejemplares similares
-
Telepsychiatry for the Elderly
por: Stoppe, G.
Publicado: (2022) -
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023) -
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
por: Cacabelos, Ramon
Publicado: (2020) -
Legal and Forensic Issues in Telepsychiatry
por: Goethals, K.
Publicado: (2022) -
WPA Global Guidelines for Telepsychiatry
por: Mucic, D.
Publicado: (2021)